Latanoprost/timolol fixed combination for the treatment of glaucoma. (Q38117401)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Latanoprost/timolol fixed combination for the treatment of glaucoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Andreas Katsanos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Irini C Voudouragkaki

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Murat Irkec

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

28 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1815-1827

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23806084%20AND%20SRC:MED&resulttype=core&format=json

The number of people with glaucoma worldwide in 2010 and 2020

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Delaying treatment of ocular hypertension: the ocular hypertension treatment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Fixed-dose combinations improve medication compliance: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Timolol/dorzolamide combination therapy as initial treatment for intraocular pressure over 30 mm Hg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Fixed combinations of topical glaucoma medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Glaucoma: a review of adjunctive therapy and new management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

24-hour intraocular pressure and ocular perfusion pressure in glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

A comprehensive perspective on patient adherence to topical glaucoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Patient adherence and medical treatment outcomes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Adherence and persistence with glaucoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Compliance Barriers in Glaucoma: A Systematic Classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Using fixed-dose combination therapies to achieve blood pressure goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

A systematic review of the associations between dose regimens and medication compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Prostaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Preservatives in eyedrops: the good, the bad and the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

The influence of prior therapy on the success of trabeculectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Perspectives in the medical treatment of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Latanoprost : an update of its use in glaucoma and ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

A review of the use of latanoprost for glaucoma since its launch

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Ocular and systemic pharmacokinetics of latanoprost in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Bioavailability in the human eye of a fixed combination of latanoprost and timolol compared to monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

The effect of adding prostaglandin F2 alpha-isopropylester to timolol in patients with open angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

A review of additivity to prostaglandin analogs: fixed and unfixed combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

A meta-analysis of topical prostaglandin analogs in the treatment of chronic angle-closure glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Meta-analysis of medical intervention for normal tension glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

The intraocular pressure-lowering effect of prostaglandin analogs combined with topical β-blocker therapy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: A prospective, observational, noninterventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

A comparison of the fixed combination of latanoprost and timolol with its individual components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Side effects associated with prostaglandin analog therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Putative side effects of prostaglandin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

The use of prostaglandin analogs in the uveitic patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Efficacy and safety of latanoprost in eyes with uveitic glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Periorbital Fat Atrophy — An Unfamiliar Side Effect of Prostaglandin Analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482

Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.813482